Immunoglobulin treatment in refractory m
โ
Anat Achiron; Yoram Barak; Shmuel Miron; Ida Sarova-Pinhas
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 134 KB
๐ 2 views
Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia